INmune Bio
INMB
11 hedge funds and large institutions have $1.62M invested in INmune Bio in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 1 closing their positions.
400% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 1
332% more capital invested
Capital invested by funds: $375K → $1.62M (+$1.25M)
57% more funds holding
Funds holding: 7 → 11 (+4)
2.17% more ownership
Funds ownership: 0.37% → 2.54% (+2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAIM
Financial Advocates Investment Management
Olympia,
Washington
|
+$1.66M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$59.2K |
| 3 |
CCM
Covington Capital Management
Los Angeles,
California
|
+$7.4K |
| 4 |
BlackRock
New York
|
+$6.71K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$6.65K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TPWA
TRUE Private Wealth Advisors
Salem,
Oregon
|
-$9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FAIM
1
Financial Advocates Investment Management
Olympia,
Washington
| $1.33M | +$1.66M | +224,667 | New |
|
|
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $243K | +$59.2K | +8,000 | +24% |
|
|
3
BlackRock
New York
| $24K | +$6.71K | +907 | +30% |
|
|
4
Bank of America
Charlotte,
North Carolina
| $10K | +$6.65K | +898 | +112% |
|
|
CCM
5
Covington Capital Management
Los Angeles,
California
| $6K | +$7.4K | +1,000 | New |
|
6
Victory Capital Management
San Antonio,
Texas
| $5K | +$6.24K | +843 | New |
|
7
UBS Group
Zurich,
Switzerland
| $4K | +$2.95K | +399 | +139% |
|
|
AG
8
Advisor Group
Phoenix,
Arizona
| $1K | – | – | – |
|
|
LTFS
9
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $1K | +$1.51K | +204 | New |
|
|
TPWA
11
TRUE Private Wealth Advisors
Salem,
Oregon
| – | -$9K | -1,000 | Closed |
|
12
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$222 | +30 | New |
|
INMB Hedge Fund Activity: Q3 2019 in Review
11 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in INmune Bio (INMB) for Q3 2019, worth a combined $1.62M — up 332% from $375K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new INMB positions and 1 closed out — a net gain of 4 holders — while 4 added to existing stakes and 0 trimmed.
The largest buyer was Financial Advocates Investment Management, opening a new position worth an estimated $1.66M. The largest seller was TRUE Private Wealth Advisors, exiting entirely with an estimated $9K sold.
- 11 institutional investors held INmune Bio (INMB) as of Q3 2019, up from 7 in Q2 2019.
- Funds reported $1.62M of INmune Bio stock for Q3 2019, up 332% quarter-over-quarter.
- 5 funds opened new INmune Bio positions in Q3 2019 and 1 closed out, a net change of +4 holders.
- The largest INmune Bio buyer in Q3 2019 was Financial Advocates Investment Management, an estimated $1.66M added.
- The largest INmune Bio seller in Q3 2019 was TRUE Private Wealth Advisors, an estimated $9K sold.
Based on aggregated 13F filings for Q3 2019.